Fusen Pharmaceutical Company Limited
HKEX:1652.HK
1 (HKD) • At close September 11, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Fusen Pharmaceutical Company Limited |
Symbool | 1652.HK |
Munteenheid | HKD |
Prijs | 1 |
Beurswaarde | 745,035,000 |
Dividendpercentage | 0% |
52-weken bereik | 0.76 - 1.6 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Zhiming Cao |
Website | https://www.fusenyy.com |
An error occurred while fetching data.
Over Fusen Pharmaceutical Company Limited
Fusen Pharmaceutical Company Limited, an investment holding company, manufactures and sells pharmaceutical products in the People's Republic of China. The company's product portfolio includes Shuanghuanglian-based cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections; and flunarizine hydrochloride capsules and compound ferrous sulfate granules, as well as Yuanhu Zhitong oral solutions,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (HKD)
Cijfers zijn in miljoenen (HKD)